Coronavirus Disease (COVID-19) in Nigeria: Mitigating the Global Pandemic

Olayinka Rasheed Ibrahim 1 * , Yetunde T Olasinde 2
More Detail
1 Department of Paediatrics, Federal Medical Centre, Katsina, Nigeria
2 Department of Paediatrics, Bowen University, Iwo and Bowen University Teaching Hospital, Ogbomoso, Nigeria
* Corresponding Author
J CLIN MED KAZ, Volume 1, Issue 55, pp. 36-38.
Download Full Text (PDF)


The confirmation of Covid-19 in Nigeria is not unexpected given the global spread of the disease that originated from China. With an estimated 200 million people and an infectious disease vulnerability index of 0.27, a poorly managed case of Covid-19 may worsen the global pandemic. Hence, we examined the peculiarities of Nigeria as a nation and suggested ways of curtailing further spread of the disease in the country.


Ibrahim OR, Olasinde YT. Coronavirus Disease (COVID-19) in Nigeria: Mitigating the Global Pandemic. Journal of Clinical Medicine of Kazakhstan. 2020;1(55):36-8.


  • H. Lu, C. W. Stratton, Y. W. Tang. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J. Med. Virol. 2020; 92:401–402.
  • D. S. Hui et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020; 91:264–266.
  • Coronavirus Situation Report, “Coronavirus disease 2019 (COVID-19)” 2020.
  • T. Lancet and I. Diseases, “Challenges of coronavirus disease 2019”. Lancet Infect. Dis. 2020; 2019(20):30304.
  • A. R. Sahin et al. 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. EJMO. 2020; 4(1):1–7.
  • Nigeria Centre for Disease Control, “First case of coronavirus disease confirmed in Nigeria” 2019. [Online]. Available: [Accessed: 02-Mar-2020].
  • M. Moore, B. Gelfeld, A. Okunogbe, C. Paul. Identifying Future Disease Hot Spots: Infectious Disease Vulnerability Index. 2019; Santa Monica, Calif: Rand Corporation, 2017.
  • C. Huang et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497–506.
  • N. Chen et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507–513.
  • Q. Li et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N. Engl. J. Med. 2020; 1–8.
  • I. I. Bogoch, A. Watts, A. Thomas-Bachli, C. Huber, M. U. G. Kraemer, K. Khan. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J. Travel Med. 2020; 1–3.
  • C. Rothe et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N. Engl. J. Med. 2020; 2019–2020.
  • Nigeria Centre for Disease Control, “Frequently ask questions on coronavirus,” 2020. [Online]. Available: [Accessed: 02-Mar-2020].
  • J. N. Nkengasong and W. Mankoula. Comment Looming threat of COVID-19 infection in Africa : act collectively , and fast. Lancet. 2020; 6736 (20):19–20.
  • COVID-19: fighting panic with information. Lancet. 2020; 395 (10224):537.